Pharmacodynamic properties of antiplatelet agents: current knowledge and future perspectives.
about
Targeting renal purinergic signalling for the treatment of lithium-induced nephrogenic diabetes insipidus.Increased Benefit With Vorapaxar Use in Patients With a History of Myocardial Infarction and Diabetes Mellitus: What the Data Show Us.P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.Influence of genetic variations on levels of inflammatory markers of healthy subjects at baseline and one week after clopidogrel therapy; results of a preliminary studyDynamic platelet adhesion in patients with an acute coronary syndrome: The effect of antiplatelet therapy.Microfludic platforms for the evaluation of anti-platelet agent efficacy under hyper-shear conditions associated with ventricular assist devices.
P2860
Pharmacodynamic properties of antiplatelet agents: current knowledge and future perspectives.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pharmacodynamic properties of ...... ledge and future perspectives.
@en
type
label
Pharmacodynamic properties of ...... ledge and future perspectives.
@en
prefLabel
Pharmacodynamic properties of ...... ledge and future perspectives.
@en
P2093
P2860
P356
P1476
Pharmacodynamic properties of ...... ledge and future perspectives.
@en
P2093
Alexandros D Tselepis
Ioannis A Goudevenos
Kallirroi I Kalantzi
Maria E Tsoumani
P2860
P304
P356
10.1586/ECP.12.19
P407
P577
2012-05-01T00:00:00Z